Kalydeco: A Price Too High to Pay?

(MedPage Today) -- A MedPage Today/Milwaukee Journal Sentinel report revealed the staggering annual treatment cost for the cystic fibrosis drug ivacaftor (Kalydeco) as part of an investigation of venture philanthrophy -- now a JAMA Viewpoint echoes those findings.
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news